Dr Daniela van Vuuren is Chief Scientific Officer at Novartis Australia & New Zealand, with over two decades of experience in medical affairs and scientific leadership. She holds a PhD in Pharmacology and Toxicology from the University of Auckland and has led strategic medical initiatives across ophthalmology, medical excellence, and broader therapeutic areas. Daniela is known for her ability to translate complex scientific data into actionable insights that support healthcare professionals and improve patient outcomes. Her leadership spans both operational and strategic domains, including interim and permanent executive roles. Passionate about innovation and evidence-based medicine, she plays a key role in shaping Novartis’ scientific direction in the region. Daniela is also a strong advocate for multidisciplinary collaboration and advancing cardiovascular care through community-based models.